Ads
related to: g-protein-coupled receptors (gpcrs)
Search results
FMR LLC Adjusts Stake in Longboard Pharmaceuticals Inc
GuruFocus.com via Yahoo Finance· 7 months agoOverview of FMR LLC (Trades, Portfolio)'s Recent Stock Transaction On October 31, 2023, FMR LLC...
Longboard Pharmaceuticals Inc Reports Full Year 2023 Financial Results
GuruFocus.com via Yahoo Finance· 3 months agoFinancial Position: As of January 31, 2024, Longboard Pharmaceuticals Inc (NASDAQ:LBPH) reported cash, cash equivalents, and short-term investments of approximately $272.4 million. Research ...
Avrobio’s road ends in reverse merger with Tim Springer-backed startup
BioPharma Dive via Yahoo Finance· 4 months agoThe gene therapy developer’s demise has given Tectonic Therapeutic, a GPCR-focused startup founded...
Longboard Pharmaceuticals Inc. (LBPH) Q1 2024 Earnings: Financial and Strategic Developments
GuruFocus.com via Yahoo Finance· 1 month agoNet Loss: Reported a net loss of $14.986 million for Q1 2024, which was better than the estimated net loss of $15.98 million. Earnings Per Share (EPS): Recorded an EPS of -$0.42, surpassing ...
2 “Strong Buy” Penny Stocks With Over 300% Upside on the Horizon
TipRanks via Yahoo Finance· 2 years agoFinding returns is the point of investing, it’s the path to profits and prosperity. But how to get...
AI Advancements Could Be Boon for Biotech Industry
ETF Trends via Yahoo Finance· 5 months agoGenerative artificial intelligence was a point of emphasis for investors in 2023. That movement is just getting started. One exciting element about AI...
AbCellera Biologics Inc. (ABCL) Q3 2022 Earnings Call Transcript
Motley Fool· 2 years agoImage source: The Motley Fool. AbCellera Biologics Inc. (NASDAQ: ABCL)Q3 2022 Earnings CallNov 08,...
Q1 2024 Predictive Oncology Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 3 weeks agoParticipants Glenn Garmont; Investor Relations; LifeSci Venture Partners LP Raymond Vennare; Chairman of the Board, Chief Executive Officer; Predictive Oncology Inc Josh Blacher; Interim Chief ...
AbbVie, Sosei Build In 2020 Pact With New Neurological Disease-Focused Agreement
Benzinga via Yahoo Finance· 2 years agoSosei Group Corporation and AbbVie Inc (NYSE: ABBV) announced a new drug discovery collaboration and...
Cerevance raises $47m to fund Phase III trial for lead Parkinson’s therapy
Clinical Trials Arena via Yahoo Finance· 1 month agoUS-based Cerevance has secured $47m in Series B-1 extension funding to finance the upcoming Phase...